Apollon Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9M | Buy |
80,517
+508
| +0.6% | +$94.3K | 0.3% | 67 |
|
|
2025
Q1 | $16.8M | Buy |
80,009
+779
| +1% | +$163K | 0.37% | 53 |
|
|
2024
Q4 | $14.1M | Buy |
79,230
+8,209
| +12% | +$1.46M | 0.32% | 63 |
|
|
2024
Q3 | $14M | Buy |
71,021
+2,590
| +4% | +$511K | 0.4% | 51 |
|
|
2024
Q2 | $11.7M | Buy |
68,431
+1,156
| +2% | +$198K | 0.36% | 55 |
|
|
2024
Q1 | $12.3M | Buy |
67,275
+444
| +0.7% | +$80.9K | 0.39% | 51 |
|
|
2023
Q4 | $10.4M | Buy |
66,831
+18,902
| +39% | +$2.93M | 0.36% | 53 |
|
|
2023
Q3 | $7.14M | Sell |
47,929
-309
| -0.6% | -$46.1K | 0.36% | 57 |
|
|
2023
Q2 | $6.5M | Sell |
48,238
-2,798
| -5% | -$377K | 0.31% | 67 |
|
|
2023
Q1 | $8.13M | Buy |
51,036
+3,935
| +8% | +$627K | 0.5% | 36 |
|
|
2022
Q4 | $7.61M | Buy |
47,101
+5,582
| +13% | +$902K | 0.54% | 33 |
|
|
2022
Q3 | $5.57M | Buy |
41,519
+1,670
| +4% | +$224K | 0.46% | 39 |
|
|
2022
Q2 | $6.1M | Sell |
39,849
-167
| -0.4% | -$25.6K | 0.51% | 36 |
|
|
2022
Q1 | $6.49M | Sell |
40,016
-2,219
| -5% | -$360K | 0.46% | 39 |
|
|
2021
Q4 | $5.72M | Buy |
42,235
+17,668
| +72% | +$2.39M | 0.43% | 46 |
|
|
2021
Q3 | $2.65M | Buy |
24,567
+10,118
| +70% | +$1.09M | 0.36% | 54 |
|
|
2021
Q2 | $1.63M | Sell |
14,449
-221
| -2% | -$24.9K | 0.29% | 62 |
|
|
2021
Q1 | $1.59M | Buy |
14,670
+12,167
| +486% | +$1.32M | 0.31% | 64 |
|
|
2020
Q4 | $268K | Sell |
2,503
-1,698
| -40% | -$182K | 0.07% | 166 |
|
|
2020
Q3 | $368K | Buy |
4,201
+2,028
| +93% | +$178K | 0.17% | 102 |
|
|
2020
Q2 | $213K | Buy |
+2,173
| New | +$213K | 0.12% | 98 |
|